Literature DB >> 6412009

The role of phospholipase C in platelet responses.

E G Lapetina, W Siess.   

Abstract

Degradation of inositides induced by phospholipase C in activated platelets leads to the formation of 1,2-diacylglycerol (1,2-DG) and its phosphorylated product, phosphatidic acid (PA). We have studied the relationship between activation of phospholipase C and the appearance of specific platelet responses, such as phosphorylation of proteins, shape change, release reaction and aggregation induced by different stimuli such as thrombin, platelet-activating factor, collagen, arachidonic acid (AA) and dihomogamma linolenic acid. A low degree of platelet activation induces only shape change which is associated with partial activation of phospholipase C (formation of phosphatidic acid), and phosphorylation of both a 40K molecular weight protein (protein kinase C activation) and a 20K molecular weight protein (myosin light chain). A higher degree of platelet activation induces aggregation, release of serotonin and a higher level of phospholipase C and protein kinase C activities. Metabolism of AA occurs concomitantly to aggregation and serotonin release, but AA metabolites are not related to the shape change of human platelets. Platelet shape change and the initial activation of phospholipase C induced by thrombin or platelet-activating factor is independent of the metabolites derived from cyclo-oxygenase activity. Further activation of phospholipase C which occurs during platelet aggregation and release reaction is, however, partly dependent on cyclo-oxygenase metabolites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412009     DOI: 10.1016/0024-3205(83)90654-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.

Authors:  B Rosenkranz; C Fischer; C O Meese; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

3.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Dose-dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo.

Authors:  P P Godfrey; F Bochner; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

5.  1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis.

Authors:  S P Watson; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets.

Authors:  W Siess; M Stifel; H Binder; P C Weber
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

7.  myo-Inositol 1,4,5-trisphosphate stimulates protein phosphorylation in saponin-permeabilized human platelets.

Authors:  E G Lapetina; S P Watson; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 8.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.